[Infections in neutropenic patients].
Berenguer
J
J
Servicio de Microbiología Clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañón, Madrid.
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000150:complications* / Q000188:drug therapy; D002404:Catheterization / Q000009:adverse effects; D003115:Colony-Stimulating Factors / Q000627:therapeutic use; D003428:Cross Infection / Q000517:prevention & control; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005334:Fever / Q000209:etiology; D006020:Glycopeptides / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D016867:Immunocompromised Host; D007769:Lactams; D009181:Mycoses / Q000150:complications*; D009503:Neutropenia / Q000150:complications* / Q000628:therapy; D009894:Opportunistic Infections / Q000150:complications / Q000188:drug therapy
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D003115:Colony-Stimulating Factors; D006020:Glycopeptides; D007769:Lactams
Infecciones en pacientes neutropénicos.